Aparna Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 881.00 Cr
- Paid Up Capital ₹ 385.77 Cr
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 101.80 Cr
- Revenue Growth %
- Profit Growth -189.04%
- Ebitda -193.27%
- Net Worth 256.01%
- Total Assets 15.17%
About Aparna Pharmaceuticals
Aparna Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 September 2020 (Four years and five months 0 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 881.00 Cr and a paid-up capital of Rs 385.77 Cr.
The company currently has active open charges totaling ₹101.80 Cr.
The Key Managerial Personnel (KMP) at Aparna Pharmaceuticals Private Limited India is Deepak Makhija as COMPANY SECRETARY. Sannareddy Reddy, Rakesh Chennuru, and Pochana Reddy serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24304TG2020PTC143375
- Company No.
143375
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Sep 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Aparna Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Deepak Makhija | Company Secretary | 20-Oct-2022 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sannareddy Reddy  | Director | 01-Sep-2020 | Current |
| Rakesh Chennuru | Director | 01-Sep-2020 | Current |
| Pochana Reddy | Director | 01-Sep-2020 | Current |
Financial Performance of Aparna Pharmaceuticals.
Aparna Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 189.04% decrease in profit. The company's net worth Soared by an impressive increase of 256.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aparna Pharmaceuticals?
In 2023, Aparna Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Innroad Software Development Services Private LimitedRakesh Chennuru is a mutual person
Aparna Mines & Minerals Private LimitedSannareddy Reddy and Pochana Reddy are mutual person
- Aparna Ceramic Tiles Private Limited
Sannareddy Reddy and Pochana Reddy are mutual person
- Aparna Realty Private Limited
Sannareddy Reddy and Pochana Reddy are mutual person
- Aparna Property Holdings Private Limited
Sannareddy Reddy and Pochana Reddy are mutual person
- Aparna Enterprises Limited
Sannareddy Reddy and Pochana Reddy are mutual person
Charges (Loans)
₹101.80 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 99.36 Cr
- Others : 2.44 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 May 2024 | Hdfc Bank Limited | ₹21.68 Cr | Open |
| 30 Sep 2020 | Others | ₹2.44 Cr | Open |
| 12 Apr 2019 | Hdfc Bank Limited | ₹31.68 Cr | Open |
| 28 Feb 2019 | Hdfc Bank Limited | ₹46.00 Cr | Open |
How Many Employees Work at Aparna Pharmaceuticals?
Aparna Pharmaceuticals has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aparna Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aparna Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
